<DOC>
	<DOCNO>NCT02979704</DOCNO>
	<brief_summary>This study conduct assess status oxidative stress inflammation thrombogenesis patient hyperlipidemia compare antioxidative , anti-inflammatory antithrombogenic effect rosuvastatin atorvastatin .</brief_summary>
	<brief_title>A Comparative Study Rosuvastatin Atorvastatin Patients With Hyperlipidemia</brief_title>
	<detailed_description>Hyperlipidemia major risk factor development atherosclerosis ultimately lead cardiovascular disease ( CVD ) , important cause mortality morbidity worldwide . Atherosclerosis previously consider lipid storage disease grow evidence indicates increase oxidative stress , vascular inflammation platelet activation play important role initiation progression atherosclerosis . Among hypolipidemic drug , statin , 3-hydroxyl-3-methylglutaryl coenzyme A ( HMG-CoA ) reductase inhibitor , prove much effective . Therefore , statins widely use hypolipidemic agent . Evidence show besides hypolipidemic action statins possess antioxidative , anti-inflammatory antithrombogenic effect know pleiotropic action might play important role attenuate atherosclerotic process . However , pleiotropic effect varies different member statin . The present prospective interventional study would conduct Department Pharmacology , Department Cardiology Internal Medicine , BSMMU March 2016 August 2017 . Total 90 case select accord inclusion exclusion criterion . The case subdivide 2 group : group A B . Group A consist 45 patient receive rosuvastatin ( 5-10 ) mg orally daily Group B consist 45 patient receive atorvastatin ( 10-20 ) mg orally daily 08 week . Patient 's blood sample collect measure baseline lipid profile , malondialdehyde ( MDA ) , erythrocytic glutathione ( GSH ) , high sensitive C-reactive protein ( hs-CRP ) , prothrombin time ( PT ) , platelet count . After obtain baseline data patient assign respective group . Parameters baseline evaluate 08 week therapeutic intervention . Regularity drug intake ensure telephone , pill count , patient 's compliance sheet . Patient 's data record predetermine data sheet . Patients inform study , merit demerit easy language inform consent taken.Therefore , present study design compare antioxidative , anti-inflammatory antithrombogenic effect rosuvastatin atorvastatin hyperlipidemic patient establish superiority particular statin , provide good therapeutic option order prevent CVD related mortality morbidity .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Inclusion criterion : Age ( 2075 ) yr , male female LDL cholesterol : 160190 mg/dl , triglyceride ( TG ) : 200499 mg/dl recruit study Exclusion criterion : Patients age &lt; 25 year &gt; 75 year Patients lipid lower medication Patients take omega3 fatty acid garlic Patients history hypersensitivity member statin Patients take antiinflammatory medication ( steroid NSAIDS ) Patients take antioxidant vitamin ( vitamin A , C , E ) Patients impaired renal function Patients impair liver function Pregnant woman nurse mother Patients serious infection terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>